Login
$KLRS
$1.46 -$0.11 (7.3%) Live

Company Executives

Officer Age 2025 pay Source
Andrew Oxtoby Also a director
President and Chief Executive Officer, Director
52 $2,569,115
Liisa Bayko
Chief Financial Officer and Treasurer
Title from the Form 8-K dated Jul 20, 2026
Not stated Not reported
Matthew Feinsod
Chief Medical Officer
55 $1,673,771
Amy O'Leary Vandekop
VP, Corporate Controller
Title from the Form 4 dated Aug 27, 2026
Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 24, 2026 · updated by the 8-K of Jul 6, 2026

Directors
8
serving now
Average tenure
4.5 years
from year joined
CEO also chairs the board
No
David Hallal
Director Age On board Committees Other public boards 2025 pay Source
David Hallal
59 2018
8 years
Compensation Committee
Scholar Rock Holding Corp. $244,430
Andrew Oxtoby
52 Not stated None stated None stated Paid as CEO
Napoleone Ferrara, M.D.
69 Not stated None stated None stated $151,093
Leone Patterson
63 2025
1 year
Audit Committee · Chair
Nkarta, Inc. $145,680
Anthony P. Adamis, M.D.
67 Not stated
Audit Committee
None stated $141,905
Michael Dybbs, Ph.D.
51 Not stated
Compensation Committee · Chair
Sutro Biopharma, Inc. $143,430
Srinivas Akkaraju, M.D., Ph.D.
58 Not stated
Nominating and Corporate Governance Committee · Chair
vTv Therapeutics Inc. $140,430
Laurie Keating Joined Aug 1, 2026
- -
Audit Committee
- -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 24, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support